Total Payments
$1,910
2024 Payments
$629.61
Companies
11
Transactions
55
Medicare Patients
193
Medicare Billing
$32,238
Payment Breakdown by Category
Food & Beverage$1,848 (96.8%)
Education$61.74 (3.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,848 | 52 | 96.8% |
| Education | $61.74 | 3 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $470.88 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $229.56 | 6 | $0 (2024) |
| ABBVIE INC. | $229.14 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $194.24 | 3 | $0 (2024) |
| ITI, Inc. | $126.24 | 2 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $124.98 | 1 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $124.98 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $121.83 | 1 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $114.95 | 2 | $0 (2023) |
| Corium, LLC | $105.13 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $629.61 | 18 | Janssen Pharmaceuticals, Inc ($194.24) |
| 2023 | $1,007 | 23 | Otsuka America Pharmaceutical, Inc. ($278.04) |
| 2022 | $273.08 | 14 | ABBVIE INC. ($138.76) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: CNS | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Neuroscience | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Neuroscience | ||||||
| 05/16/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: PSYCHIATRY | ||||||
| 04/23/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: SCHIZOPHRENIA | ||||||
| 04/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Central Nervous System | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $149.98 | General |
| Category: Neuroscience | ||||||
| 01/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $7.98 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $4.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Neurology | ||||||
| 11/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2023 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $5.58 | General |
| 11/11/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 118 | 257 | $35,313 | $14,391 |
| 2022 | 1 | 44 | 181 | $29,865 | $12,668 |
| 2021 | 1 | 31 | 62 | $10,230 | $5,180 |
Total Patients
193
Total Services
500
Medicare Billing
$32,238
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 151 | $17,688 | $7,617 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 69 | $11,385 | $4,358 | 38.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 19 | 19 | $5,700 | $2,012 | 35.3% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 18 | 18 | $540.00 | $404.10 | 74.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 181 | $29,865 | $12,668 | 42.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 62 | $10,230 | $5,180 | 50.6% |
About Sandra Edwards
Sandra Edwards is a Psychiatric/Mental Health healthcare provider based in Creston, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2021. The National Provider Identifier (NPI) number assigned to this provider is 1609451632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Edwards has received a total of $1,910 in payments from pharmaceutical and medical device companies, with $629.61 received in 2024. These payments were reported across 55 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,848).
As a Medicare-enrolled provider, Edwards has provided services to 193 Medicare beneficiaries, totaling 500 services with total Medicare billing of $32,238. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Creston, IA
- Active Since 03/11/2021
- Last Updated 03/11/2021
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1609451632
Products in Payments
- VRAYLAR (Drug) $229.14
- ABILIFY ASIMTUFII (Drug) $215.33
- INVEGA SUSTENNA (Drug) $194.24
- REXULTI (Drug) $190.59
- Austedo XR (Drug) $175.48
- CAPLYTA (Drug) $126.24
- FANAPT (Drug) $124.98
- QELBREE (Drug) $124.98
- Auvelity (Drug) $121.83
- JORNAY PM (Drug) $114.95
- AZSTARYS (Drug) $105.13
- ABILIFY MAINTENA (Drug) $53.80
- ARISTADA (Drug) $50.35
- UZEDY (Drug) $42.20
- LYBALVI (Drug) $17.31
- AUSTEDO (Drug) $11.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.